Patents Do Not Measure Innovation Success
David M. Reeb and
Critical Finance Review, 2020, vol. 9, issue 1-2, 157-199
We find that a companyâ€™s patent filings and citations are not good measures of R&D success or failure, even when compared to firms in the same industry. Instead, our analysis reveals that patent counts reflect the firmâ€™s mix of product and process innovation. Intuitively, competitor infringements of process innovation are difficult to detect, suggesting these innovations are better protected via trade secret than patents. We document that non-patenting firms frequently announce valuable new products, even though they emphasize process over product innovation. Insider trading in non-patenting firms generates positive excess returns, while such activity in patenting firms yields ordinary returns. The Uniform Trade Secrets Act induced firms to switch from patenting to non-patenting, leading to lower analysts and institutional following. Financial intermediaries potentially influence the disclosure of innovation rather than research and development success (Aghion et al., 2013; Bena et al., 2017). Overall, our tests indicate that patents and citations signify the nature of innovation rather R&D success.
Keywords: Product innovation; Process innovation; Patents; Trade secrets; Productannouncements; Insider trading; Disclosure choice; Financing innovation (search for similar items in EconPapers)
JEL-codes: G30 G32 O30 O34 (search for similar items in EconPapers)
References: Add references at CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:now:jnlcfr:104.00000087
Access Statistics for this article
More articles in Critical Finance Review from now publishers
Bibliographic data for series maintained by Alet Heezemans ().